CORDIS · 856415 · H2020
ThoriumNuclearClock Thorium nuclear clocks for fundamental tests of physics
Coordinator: TECHNISCHE UNIVERSITAET WIEN (AT)
Th-229 has an exceptionally low-energy excited nuclear isomer state with an excitation energy of only a few electron volts, making it accessible to laser manipulation. With a predicted relative radiative linewidth of 1e-19, constructing a Thorium nuclear clock becomes possible that could rival todays most advanced optical atomic clocks.The few-eV transition emerges from a fortunate near-degeneracy of the two lowest nuclear energy levels. However, the Coulomb and strong-force contributions to these level energies differ on the MeV level. This makes the Th-229 nuclear level structure uniquely s…
About Horizon 2020 (2014–2020)
Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.
EU contribution: €13.8M awarded to the consortium. The project runs over approximately 6.7 years from 2020-02-01 to 2026-10-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from AT
see all →- EMPOWER — Eco-operated, Modular, highly efficient, and flexible multi-POWERtrain for long-haul heavy-duty vehicles101096028 · HORIZON · €18.0M
- M-ERA.NET3 — ERA-NET for research and innovation on materials and battery technologies, supporting the European Green Deal.958174 · H2020 · €15.0M
- iPC — individualizedPaediatricCure: Cloud-based virtual-patient models for precision paediatric oncology826121 · H2020 · €14.7M
- MORE-TEM — MOmentum and position REsolved mapping Transmission Electron energy loss Microscope951215 · H2020 · €14.0M
- PoCCardio — Personalised Medicine by using an Advanced Point-of-Care Tool for Stratified Treatment in High Risk Cardiovascular Patients (PoCCardio)101095432 · HORIZON · €14.0M
- M-ERA.NET 2 — ERA-NET for materials research and innovation685451 · H2020 · €12.8M
Other H2020 projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint programme of the members of the EUROfusion consortium633053 · DE · €678.8M
- H2020 — COST at a turning point: A unique framework for pan-European ST cooperation as clear demonstration of European values681463 · BE · €178.2M
- HBP SGA3 — Human Brain Project Specific Grant Agreement 3945539 · BE · €150.0M
- COVID-19 VACCINES — PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19101018100 · NO · €100.0M
- UNITE4TB — ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS101007873 · NL · €92.5M
- ERA4TB — EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS853989 · ES · €89.8M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the ERC-SyG funding scheme.
- What is the EU contribution?
- The European Commission contributes €13.8M toward a total project budget of €13.8M.
- Which EU programme funds it?
- The project is funded under Horizon 2020 (2014–2020), call ERC-2019-SyG.
- Who coordinates the project?
- The project is coordinated by TECHNISCHE UNIVERSITAET WIEN (AT).
- What is the project timeline?
- The project runs from 2020-02-01 to 2026-10-31 — approximately 6.7 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 856415.